Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma

Richard Turkington; Laura Knight; Rosalie Douglas; Jaine Blayney; Leanne Stevenson; Damian McManus; Andrena McCavigan; Steven Walker; Jan  Bornschein; Shona McRae; Fergus Noble; Timothy Underwood; Robert O'Neill; Stephen McQuaid; Kenneth Arthur; Jacqueline James; Martin Eatock; Denis Harkin; Rebecca C Fitzgerald; Richard Kennedy

Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma

Richard Turkington
, Laura Knight
, Rosalie Douglas
, Jaine Blayney
, Leanne Stevenson
, Damian McManus
, Andrena McCavigan
, Steven Walker
, Jan Bornschein
, Shona McRae
, Fergus Noble
, Timothy Underwood
, Robert O'Neill
, Stephen McQuaid
, Kenneth Arthur
, Jacqueline James
, Martin Eatock
, Denis Harkin
, Rebecca C Fitzgerald
, Richard Kennedy

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	4026
Pages (from-to)	4026-4026
Number of pages	1
Journal	Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology
Volume	35
Issue number	15_suppl
Publication status	Published - 01 May 2017

Access to Document

http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.4026Licence: Unspecified

Identification of targetable mediators of resistance to chemotherapy in oesophageal adenocarcinoma
Douglas, R. (Author), Turkington, R. (Supervisor) & Kennedy, R. (Supervisor), Jul 2021
Student thesis: Doctoral Thesis › Doctor of Philosophy

File

1 Article

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
Turkington, R., Knight, L., Blayney, J., Secrier, M., Douglas, R., Parkes, E., Sutton, E., Stevenson, L., McManus, D., Halliday, S., McCavigan, A., Logan, G., Walker, S., Steele, C., Perner, J., Bornscein, J., MacRae, S., Miremadi, A., McCarron, E. & McQuaid, S. & 10 others, Arthur, K., James, J., Eatock, M., O'Neill, R., Noble, F., Underwood, T., Harkin, D., Salto-Tellez, M., Fitzgerald, R. C. & Kennedy, R., 09 Mar 2019, (Early online date) In: Gut. 68, 11, p. 1918-1927 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
26 Link opens in a new tab Citations (Scopus)

441 Downloads (Pure)

Cite this

Turkington, R., Knight, L., Douglas, R., Blayney, J., Stevenson, L., McManus, D., McCavigan, A., Walker, S., Bornschein, J., McRae, S., Noble, F., Underwood, T., O'Neill, R., McQuaid, S., Arthur, K., James, J., Eatock, M., Harkin, D., Fitzgerald, R. C., & Kennedy, R. (2017). Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma. Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology, 35(15_suppl), 4026-4026 . Article 4026. http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.4026

@article{8baaa16e94874e35b1ec121f11950b4c,

title = "Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma",

author = "Richard Turkington and Laura Knight and Rosalie Douglas and Jaine Blayney and Leanne Stevenson and Damian McManus and Andrena McCavigan and Steven Walker and Jan Bornschein and Shona McRae and Fergus Noble and Timothy Underwood and Robert O'Neill and Stephen McQuaid and Kenneth Arthur and Jacqueline James and Martin Eatock and Denis Harkin and Fitzgerald, \{Rebecca C\} and Richard Kennedy",

year = "2017",

month = may,

day = "1",

language = "English",

volume = "35",

pages = "4026--4026 ",

journal = "Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15\_suppl",

}

Turkington, R, Knight, L, Douglas, R, Blayney, J, Stevenson, L, McManus, D, McCavigan, A, Walker, S, Bornschein, J, McRae, S, Noble, F, Underwood, T, O'Neill, R, McQuaid, S, Arthur, K, James, J, Eatock, M, Harkin, D, Fitzgerald, RC & Kennedy, R 2017, 'Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma', Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology, vol. 35, no. 15_suppl, 4026, pp. 4026-4026 . <http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.4026>

Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma. / Turkington, Richard; Knight, Laura; Douglas, Rosalie et al.
In: Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology, Vol. 35, No. 15_suppl, 4026, 01.05.2017, p. 4026-4026 .

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma

AU - Turkington, Richard

AU - Knight, Laura

AU - Douglas, Rosalie

AU - Blayney, Jaine

AU - Stevenson, Leanne

AU - McManus, Damian

AU - McCavigan, Andrena

AU - Walker, Steven

AU - Bornschein, Jan

AU - McRae, Shona

AU - Noble, Fergus

AU - Underwood, Timothy

AU - O'Neill, Robert

AU - McQuaid, Stephen

AU - Arthur, Kenneth

AU - James, Jacqueline

AU - Eatock, Martin

AU - Harkin, Denis

AU - Fitzgerald, Rebecca C

AU - Kennedy, Richard

PY - 2017/5/1

Y1 - 2017/5/1

M3 - Meeting abstract

SN - 0732-183X

VL - 35

SP - 4026

EP - 4026

JO - Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology

JF - Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology

IS - 15_suppl

M1 - 4026

ER -

Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma

Access to Document

Student theses

Identification of targetable mediators of resistance to chemotherapy in oesophageal adenocarcinoma

Research output

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Cite this